Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients
NCT00174343 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2011-04-22
Summary
To evaluate clinical and pathologic response rates following primary hormonal therapy by exemestane (Aromasin®)
Conditions
- Breast Neoplasms
Interventions
- DRUG
-
exemestane (Aromasin®)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-11-30
- Completion
- 2006-09-30
Countries
- France
Study Locations
More Related Trials
-
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer
NCT00649090 ·Status: COMPLETED ·Phase: PHASE4
-
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
NCT00201864 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
NCT00080613 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
NCT00767520 ·Status: COMPLETED ·Phase: PHASE2
-
Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
NCT00066586 ·Status: COMPLETED ·Phase: NA
-
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
NCT00016432 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
NCT01237327 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
NCT00793546 ·Status: TERMINATED ·Phase: PHASE2
-
Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients
NCT00128843 ·Status: COMPLETED ·Phase: PHASE2
-
Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer
NCT00143390 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
NCT00065325 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
NCT01151046 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients
NCT01638247 ·Status: COMPLETED ·Phase: PHASE3
-
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
NCT01047358 ·Status: COMPLETED
-
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane
NCT00036270 ·Status: COMPLETED ·Phase: PHASE3
-
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
NCT02598557 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
NCT02007512 ·Status: COMPLETED ·Phase: PHASE2
-
Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)
NCT01050634 ·Status: COMPLETED
-
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
NCT00003418 ·Status: UNKNOWN ·Phase: PHASE3
-
An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis
NCT01743560 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
NCT00200174 ·Status: COMPLETED ·Phase: NA
-
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
NCT01176916 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
NCT00038467 ·Status: COMPLETED ·Phase: PHASE3
-
Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
NCT00201773 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer
NCT00676663 ·Status: COMPLETED ·Phase: PHASE2